Dawkins and Pratley note that while studies show people with obesity and type 2 diabetes experience significant weight loss on a GLP-1 agonist or dual agonist, people with type 2 diabetes experience slightly less weight loss compared with those with overweight and obesity without type 2 diabetes.1-3 Counseling Tips for RDs Despite the success of these classes of weight management medications, patients can receive anywhere from a little to a lot of information on how to optimize their use since a wide variety of clinicians, from primary care providers to obesity medicine experts, prescribe them
Is MC1R the central receptor, or are MC3R/MC4R effects part of the hypothesis
While the medication may not directly impact the likelihood of quitting, its potential to reduce a major deterrentpost-cessation weight gainoffers an indirect yet meaningful advantage
Losing weight can lead to a loss of fat in the face, which can make your features look a bit sunken or hollow
By protecting mitochondria from oxidative stress, glutathione helps improve endurance, mental clarity, and overall vitality
